Clinical Trials Directory

Trials / Completed

CompletedNCT01684020

A Study Evaluating the Efficacy and Safety of ARTISS Human Fibrin Sealant as Used in External Rhinoplasty

A Prospective, Double-Blinded, Randomized Study Evaluating the Efficacy and Safety of ARTISS Human Fibrin Sealant as Used in External Rhinoplasty

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
10 (actual)
Sponsor
DeNova Research · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Rhinoplasty (nasal reconstruction i.e. "a nose job") is a surgical procedure performed on the nose to correct a medical problem or change the appearance of the nose. During the healing process, swelling and/or bruising is likely to occur. A drug called ARTISS Fibrin Sealant may or may not lessen these effects. This study is looking to see the effects of ARTISS on adhering tissue and improving wound healing in an external rhinoplasty. The purpose of this study is to evaluate the safety and effectiveness of rhinoplasty using ARTISS compared to rhinoplasty without using ARTISS in patients undergoing rhinoplasty performed through an external approach.

Conditions

Interventions

TypeNameDescription
BIOLOGICALARTISS human fibrin sealant

Timeline

Start date
2012-11-28
Primary completion
2016-04-26
Completion
2016-04-26
First posted
2012-09-12
Last updated
2020-11-02
Results posted
2020-10-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01684020. Inclusion in this directory is not an endorsement.